This page is part of the FHIR Specification (v4.5.0: R5 Preview #3). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions
Biomedical Research and Regulation Work Group | Maturity Level: N/A | Standards Status: Informative | Compartments: Not linked to any defined compartments |
Raw JSON (canonical form + also see JSON Format Specification)
Example of a film-coated tablet, using a "specified substance"
{ "resourceType": "Ingredient", "id": "example", "text": { "status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><p><b>id</b>: example</p><p><b>role</b>: <span>ActiveBase</span></p><p><b>manufacturer</b>: <a>Organization/example</a></p><blockquote><p><b>specifiedSubstance</b></p><p><b>code</b>: <span>equixabanCompany1</span></p><p><b>group</b>: <span>2</span></p></blockquote><blockquote><p><b>specifiedSubstance</b></p><p><b>code</b>: <span>equixabanCompany2</span></p><p><b>group</b>: <span>2</span></p></blockquote></div>" }, "role": { "coding": [ { "system": "http://ema.europa.eu/example/ingredientRole", "code": "ActiveBase" } ] }, "manufacturer": [ { "reference": "Organization/example" } ], "specifiedSubstance": [ { "codeCodeableConcept": { "coding": [ { "system": "http://ema.europa.eu/example/specifiedSubstance", "code": "equixabanCompany1" } ] }, "group": { "coding": [ { "system": "http://ema.europa.eu/example/specifiedSubstanceGroup", "code": "2" } ] } }, { "codeCodeableConcept": { "coding": [ { "system": "http://ema.europa.eu/example/specifiedSubstance", "code": "equixabanCompany2" } ] }, "group": { "coding": [ { "system": "http://ema.europa.eu/example/specifiedSubstanceGroup", "code": "2" } ] } } ] }
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.